Pacific Cardiovascular Associates Medical Group
Cardiologists serving all of Orange County
PCA has developed a comprehensive and validated Congestive Heart Failure (CHF) program that has been proven to improve quality of care, quality of service and reduce cost of care for CHF patients. PCA's CHF program is unique in it's approach. The finest medical professionals have been assembled to beneficially impact patients afflicted with this condition.
We have refined our management algorithms and delivery strategies to improve outcomes for patients with CHF. Our combined cardiologist, PA/NP and RN team approach ensures that our dedicated highly skilled team of multi-disciplinary professionals care for the patient through the entire continuum of their care. PCA's CHF Program will initiate the appropriate best therapy based upon evidence-based guidelines and develop a patient-specific treatment plan for each individual patient that will be implemented both in the patients’ homes as well as in our outpatient facilities and when necessary, in the inpatient setting. We work in tandem with a patients referring cardiologist or primary care physician to ensure outcomes are optimized. We employ the latest, state of the art monitoring technology and monitor patients progress continuously. While all patients with CHF benefit from our intensive patient specific efforts patients with more advanced HF benefit the most (Class II, II and IV).
To learn more about PCA's highly renown HF Program please contact Alison Ruggio, Manager of Administration and Outreach Services at (714) 445-0220.
“Congestive Heart Failure (CHF)” or “Heart Failure (HF)” remains a leading cause of death and disability in the United States. Though historically a very challenging chronic illness to diagnose and treat, it has become a huge health care dilemma, with more than 500,000 new cases diagnosed each year in the United States alone.
Many patients who are given the diagnosis of “heart failure” (HF) are in fact, misdiagnosed. Often -times, patients with non-cardiovascular pulmonary diseases are inappropriately admitted and/or treated for HF. A critically important component of any HF program is to establish criteria for correct and early definitive diagnosis. Expert early assessment of patients with reversible etiologies that can be corrected will prevent further deterioration in patients’ cardiovascular status (e.g., ischemic heart disease).